Recent Certifications & Approvals

OmniActive Health Technologies

April 13, 2010

OmniActive Health Technologies, Short Hills, NJ, has self-determined that its Lutemax line of free lutein and lutein esters are GRAS (Generally Regarded as Safe). The process involved an intensive review of safety and toxicology data by an independent panel of highly qualified scientists with extensive regulatory, pharmacology and toxicological experience. As part of the self-determination process, the expert panel was provided extensive ingredient information including the background of the ingredient, usage history, summary of anticipated daily intake and literature research. Upon completion of the material review, the panel then conducted a safety assessment. OmniActive is also currently in the process of securing self-affirmed GRAS status for its newest offering, Lutemax 2020, which delivers both lutein and zeaxanthin isomers
  • Oral Solid Dosage Outsourcing: Trends & Challenges

    Oral Solid Dosage Outsourcing: Trends & Challenges

    Tim Wright, Editor, Contract Pharma||March 1, 2017
    Despite the increasing number of biologics, oral solids remain the dominant dosage form in the pharmaceutical market.

  • Skeleton Crew: Solutions for Bone Health

    Skeleton Crew: Solutions for Bone Health

    Lisa Schofield, Contributing Writer||March 1, 2017
    Products that can help aging populations stay active and independent will be in a strong market position.

  • Formulation Strategies for  Aging Consumers

    Formulation Strategies for Aging Consumers

    Stephen Tindal, Director, Science and Technology, Catalent Pharma Solutions||March 1, 2017
    Convenience, flavor and novel combinations of ingredients can help offer better product experiences.